Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: Report of 12 cases from single institution experience

Japanese Journal of Clinical Oncology

Volumn 38, Issue 6, 2008, Pages 426-431

  Chin, Keisho ^a,c   Baba, Satoshi ^a   Hosaka, Hisashi ^a   Ishiyama, Akiyoshi ^a   Mizunuma, Nobuyuki ^a   Shinozaki, Eiji ^a   Suenaga, Mitsukuni ^a   Kozuka, Takuyo ^a   Setoy , Yasuyuki ^a   Yamamoto, Noriko ^b   Hatake, Kiyohiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

^c NONE   (Japan)

Author keywords

Chemotherapy; Cisplatin; CPT 11; Esophageal cancer; Small cell carcinoma

Indexed keywords

ANTIDIARRHEAL AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; IRINOTECAN; LOPERAMIDE; METHOTREXATE; NEDAPLATIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DIARRHEA; DRUG FATALITY; DRUG RESPONSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INFECTION; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PROGNOSIS; RECURRENT CANCER; SIDE EFFECT; SMALL CELL CARCINOMA; SURVIVAL TIME; THROMBOCYTOPENIA; ESOPHAGUS TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 46349094423     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn041     Document Type: Article

References (21)

1. Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: A review. J Clin Oncol 2004;22:2730-9.
2. McFadden DW, Rudnicki M, Talamini MA. Primary small cell carcinoma of the esophagus. Ann Thorac Surg 1989;47:477-80.
3. Van Der Gaast A, Verwey J, Prins E, Splinter TA. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer 1990;65:422-4.
4. Ohmura Y, Takiyama W, Mandai K, Doi T, Nishikawa Y. Small cell carcinoma of the esophagus: A case report. Jpn J Clin Oncol 1997;27:95-100.
5. Kelsen DP, Weston E, Kurtz R, Cvitkovic E, Lieberman P, Golbey RB. Small cell carcinoma of the esophagus, treatment by chemotherapy alone. Cancer 1980;45:1558-61.
6. Fukada M, Nishio K, Kanzwa F, Ogasawara H, Ishida T, Arioka H et al. Synergism between cisplatin and topoisomerase I inhibitors. NB-506 and SN-38, in human small-cell lung cancer cells. Cancer Res 1996;56:789-93.
7. Kudoh S, Fujiwara Y, Takada Y, Yamamoto H, Kinoshita A, Ariyoshi Y et al. Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. J Clin Oncol 1998; 16: 1068-74.
8. Boku N, Ohtsu A, Shimada Y, Shirao K, Seki S, Saito H et al. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 1999;17:319-23.
9. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
10. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14,
11. Japanese Society for Esophageal Disease. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 8th edn. Tokyo: Kanehara 1992.
12. McKeown F. Oat cell carcinoma of the esophagus. J Pathol Bacteriol 1952;64:889-91.
13. Beyer KL, Marshall JB, Diaz-Arias AA, Loy TS. Primary small cell carcinoma of the esophagus. Report of 11 cases and review of the literature. J Clin Gastroenterol 1991;13:135-41.
14. Komura Y, Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S et al. A case of small cell carcinoma of esophagus successfully treated by chemotherapy with CPT-11 and CDDP. Nippon Shokakibyo Gakkai Zasshi 2001;98:25-30, (in Japanese).
15. Endo K, Kohnoe S, Toh Y, Haraguchi M, Nishiyama K, Okamura T et al. A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin. J Exp Clin Cancer Res 2005;24:647-50.
16. Takada M, Fukuoka M, Kawahara M, Sugiura T Yokoyama A, Yokota S et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104 (JCOG9104). J Clin Oncol 2002;20:3054-60.
17. Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vipcristine. J Clin Oncol 1996;14:806-13.
18. Casas F, Ferrer F, Farrus B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: A review of the literature with emphasis on therapy and prognosis. Cancer 1997;80:1366-72.
19. Bennouna J, Bardet E, Deguiral P, Douillard JY. Small cell carcinoma of the esophagus: Analysis of 10 cases and review of the published data. Am J Clin Oncol 2000;23:455-9.
20. Medgyesy CD, Wolff RA, Putnam JB, Ajani JA. Small cell carcinoma of the esophagus: The University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer 2000;88: 262-7.
21. Yachida S, Matsushita K, Usuki H, Wanibuchi H, Maeba T, Maeta H. Long-term survival after resection for small cell carcinoma of the esophagus. Ann Thorac Surg 2001;72:596-7.